Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Carcinoma, Hepatocellular 9Stomach Neoplasms 3Small Cell Lung Carcinoma 2Ovarian Neoplasms 2Gastric Adenocarcinoma 2Advanced Gastric Cancer 2Thymic epithelial tumor 1Solid Tumor 1Sarcoma 1Pancreatic Neoplasms 1Ovarian Cancer Recurrent 1Neuroendocrine Tumors 1Locally Advanced Gastric Cancer 1Liver Neoplasms 1Liposarcoma 1Esophageal Neoplasms 1Endometrial Neoplasms 1Carcinoma, Ovarian Epithelial 1Carcinoma, Non-Small-Cell Lung 1

Interventions

apatinib 1Platinum Compounds 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Ovarian Cancer Recurrent × apatinib × Clear all
NCT06102707 2023-10-26

The Efficacy and Safety of Fluzopril Combined With Apatinib in Maintenance Treatment of Platinum Resistant Recurrent Ovarian Cancer Patients

Qilu Hospital of Shandong University

Phase NA Not yet recruiting
50 enrolled
Gynecologic

Ovarian Cancer Recurrent

Data powered by HemOnc (CC BY 4.0) Colophon âš¡